Skip to content

Clinical trials

Observational Thrombosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Phase: Observational Country / region: United States Clear all

112 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20054
20064
20076
20085
20093
20101
20114
20126
20134
20145
20152
20166
20176
20183
20198
20207
20216
20225
20234
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Recruiting19
Unknown status12
Terminated5
Withdrawn4
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
HemoSonics LLC19
American Thrombosis and Hemostasis Network3
Brigham and Women's Hospital3
The University of Texas Health Science Center, Houston3
Boston Children's Hospital2
Entegrion, Inc.2
Haemonetics Corporation2
National Heart, Lung, and Blood Institute (NHLBI)2
National Human Genome Research Institute (NHGRI)2
University of Arizona2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis112
Hemorrhage16
Venous Thrombosis13
Hemostatic Disorders10
Pulmonary Embolism8
Thromboembolism8
Venous Thromboembolism8
Inflammation7
Blood Loss, Surgical5
Cardiovascular Diseases5

Trials

Showing 1 to 25 of 112. Each trial links to its page on Pharma Observatory.

12 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.